Sharism- Lifestyle
Author:
Relmada Therapeutics
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
May 7, 2026
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
May 5, 2026
Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing
March 26, 2026
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
March 26, 2026
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
March 19, 2026
Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
March 12, 2026
Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
March 9, 2026